Codexis vs FutureFuel
CDXS and FF side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CDXS and FF compare
FutureFuel is the larger company, worth 1.9 times as much as Codexis ($249M against $130M).
Codexis grew revenue faster over the last twelve months (35.9% versus −7.6% for FutureFuel).
FutureFuel keeps more of each dollar of sales as profit, with a net margin of −19.9% compared with −39.6% at Codexis.
FutureFuel pays a dividend yielding 2.5%; Codexis does not pay one.
FutureFuel scores higher on the StockData Score (7 against 5 for Codexis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CDXS | FF |
|---|---|---|
| Size and price | ||
| Market cap | $130M | $249M |
| Share price | $1.19 | $5.67 |
| Change, 1 year | −50.8% | 44.3% |
| Change, 5 years | −97.0% | −27.4% |
| Beta (5Y) | 2.41 | 0.87 |
| Employees | 146 | 493 |
| StockData Score | ||
| Total score | 5 | 7 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 1 | 1 |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 1 (better) |
| Valuation | ||
| P/S | 1.7× | 1.6× (better) |
| P/B | 4.0× | 1.6× (better) |
| FCF yield | −9.3% (better) | −20.5% |
| Fair value | $1.22 | $4.62 |
| Margin of safety | 2.1% (better) | −22.8% |
| Growth | ||
| Revenue growth (TTM) | 35.9% (better) | −7.6% |
| Revenue growth, 5Y average | 0.38% (better) | −14.1% |
| Profitability | ||
| Gross margin | 87.0% (better) | −11.1% |
| Operating margin | −35.6% | −20.8% (better) |
| Net margin | −39.6% | −19.9% (better) |
| FCF margin | −15.7% (better) | −33.2% |
| Return on equity | −69.4% | −18.3% (better) |
| Return on invested capital | −91.8% | −24.7% (better) |
| Financial health | ||
| Debt / equity | 1.24 (better) | 0.00 |
| Interest coverage | – | −212.1× |
| Current ratio | 3.06 | 4.06 (better) |
| Altman Z-score | −6.05 | 2.79 (better) |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | – | 2.5% |
| Shareholder yield | 0.00% | 2.5% (better) |
| Ownership | ||
| Held by institutions | 63.7% | 38.6% |
| Held by insiders | 2.2% | 40.5% |
| Insider net buying, 12 months | −$7.6M | $90.8K (better) |
| Short interest, % of float | 4.5% | 5.0% |
Go deeper
- CDXS stock overview
- CDXS income statement
- CDXS valuation and score
- FF stock overview
- FF income statement
- FF valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.